drug
lamotrigine ODT
Marketedupdated 3mo agoby Nordic Pharma Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying lamotrigine ODT
- phase3A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- phase1A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants
- phase1Lamotrigine 25 mg Chewable Tablets, Non-Fasting
- phase1Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
- phase1Bioequivalence Study of 200 mg Lamotrigine Tablet Under Non-Fasting Conditions
- phase1Lamotrigine 25 mg Chewable Tablets, Fasting
- phase1Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg
- phase1Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that